Bernard J. Zovighian - 03 May 2024 Form 4/A Insider Report for Edwards Lifesciences Corp (EW)

Role: CEO, Director
Signature: /s/ Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 03 May 2024
Transactions value $: $0
Form type: 4/A
Filing time: 13 Jun 2024, 21:18:36 UTC
Date Of Original Report: 07 May 2024
Previous filing: 01 Aug 2023
Next filing: 09 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	EW	Common Stock						3.27K	03 May 2024	401(k)	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Total reflects an acquisition of 580.2601 shares of the Issuer's Common Stock on May 6, 2024 under the Issuer's 401(k) Plan in a transaction exempted by Rule 16b-3, as well as 2,558 shares held under the Issuer's 401(k) Plan that were previously reported as directly held.

Remarks:

This amendment to the Form 4 filed on May 7, 2024 by the Reporting Person is filed to remove the reporting of the acquisition of shares described in Footnote 1, as it was an exempt transaction in the Issuer's Common Stock pursuant to Section 16b-3(c) of the Securities Exchange Act of 1934, as amended, and to disclose the number of shares beneficially owned indirectly by the Reporting Person as represented on the most recent statement of the Issuer's 401(k) Plan Administrator.